View in EDS

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.

Saved in:
Bibliographic Details
Title: T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.
Authors: Ali M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Giannakopoulou E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Li Y; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lehander M; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Virding Culleton S; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Yang W; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Knetter C; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Odabasi MC; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany., Bollineni RC; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yang X; Parker Institute for Cancer Immunotherapy, Howard Hughes Medical Institute, Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Foldvari Z; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Böschen ML; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Taraldsrud E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Strønen E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Toebes M; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hillen A; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Mazzi S; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Janssen GMC; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Kolstad A; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital Radiumhospitalet, Oslo, Norway., Tjønnfjord GE; Department of Haematology, Oslo University Hospital and KG Jebsen Center for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lie BA; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway., Griffioen M; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Lehmann S; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden., Osnes LT; Department of Immunology, Oslo University Hospital, Oslo, Norway., Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway., Garcia KC; Parker Institute for Cancer Immunotherapy, Howard Hughes Medical Institute, Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Schumacher TN; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, the Netherlands., van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Leisegang M; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany.; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL, USA.; German Cancer Consortium, partner site Berlin, Berlin, Germany.; German Cancer Research Center, Heidelberg, Germany., Jacobsen SEW; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden.; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Woll P; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. johanna.olweus@medisin.uio.no.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. johanna.olweus@medisin.uio.no.
Source: Nature biotechnology [Nat Biotechnol] 2022 Apr; Vol. 40 (4), pp. 488-498. Date of Electronic Publication: 2021 Dec 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34873326
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ali+M%22">Ali M</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Giannakopoulou+E%22">Giannakopoulou E</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lehander+M%22">Lehander M</searchLink>; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Virding+Culleton+S%22">Virding Culleton S</searchLink>; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Yang+W%22">Yang W</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Knetter+C%22">Knetter C</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Odabasi+MC%22">Odabasi MC</searchLink>; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bollineni+RC%22">Bollineni RC</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; Parker Institute for Cancer Immunotherapy, Howard Hughes Medical Institute, Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Foldvari+Z%22">Foldvari Z</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Böschen+ML%22">Böschen ML</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Taraldsrud+E%22">Taraldsrud E</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Strønen+E%22">Strønen E</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Toebes+M%22">Toebes M</searchLink>; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hillen+A%22">Hillen A</searchLink>; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Mazzi+S%22">Mazzi S</searchLink>; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22de+Ru+AH%22">de Ru AH</searchLink>; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Janssen+GMC%22">Janssen GMC</searchLink>; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kolstad+A%22">Kolstad A</searchLink>; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Tjønnfjord+GE%22">Tjønnfjord GE</searchLink>; Department of Haematology, Oslo University Hospital and KG Jebsen Center for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lie+BA%22">Lie BA</searchLink>; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Griffioen+M%22">Griffioen M</searchLink>; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lehmann+S%22">Lehmann S</searchLink>; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Osnes+LT%22">Osnes LT</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Buechner+J%22">Buechner J</searchLink>; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Garcia+KC%22">Garcia KC</searchLink>; Parker Institute for Cancer Immunotherapy, Howard Hughes Medical Institute, Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schumacher+TN%22">Schumacher TN</searchLink>; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Veelen+PA%22">van Veelen PA</searchLink>; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Leisegang+M%22">Leisegang M</searchLink>; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany.; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL, USA.; German Cancer Consortium, partner site Berlin, Berlin, Germany.; German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jacobsen+SEW%22">Jacobsen SEW</searchLink>; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden.; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Woll+P%22">Woll P</searchLink>; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Olweus+J%22">Olweus J</searchLink>; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. johanna.olweus@medisin.uio.no.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. johanna.olweus@medisin.uio.no.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229604648%22">Nature biotechnology</searchLink> [Nat Biotechnol] 2022 Apr; Vol. 40 (4), pp. 488-498. <i>Date of Electronic Publication: </i>2021 Dec 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Publishing%22">Nature America Publishing </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9604648 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1696 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210870156%22">10870156 </searchLink><i>NLM ISO Abbreviation: </i>Nat Biotechnol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34873326
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41587-021-01089-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 488
    Titles:
      – TitleFull: T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ali M
      – PersonEntity:
          Name:
            NameFull: Giannakopoulou E
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Lehander M
      – PersonEntity:
          Name:
            NameFull: Virding Culleton S
      – PersonEntity:
          Name:
            NameFull: Yang W
      – PersonEntity:
          Name:
            NameFull: Knetter C
      – PersonEntity:
          Name:
            NameFull: Odabasi MC
      – PersonEntity:
          Name:
            NameFull: Bollineni RC
      – PersonEntity:
          Name:
            NameFull: Yang X
      – PersonEntity:
          Name:
            NameFull: Foldvari Z
      – PersonEntity:
          Name:
            NameFull: Böschen ML
      – PersonEntity:
          Name:
            NameFull: Taraldsrud E
      – PersonEntity:
          Name:
            NameFull: Strønen E
      – PersonEntity:
          Name:
            NameFull: Toebes M
      – PersonEntity:
          Name:
            NameFull: Hillen A
      – PersonEntity:
          Name:
            NameFull: Mazzi S
      – PersonEntity:
          Name:
            NameFull: de Ru AH
      – PersonEntity:
          Name:
            NameFull: Janssen GMC
      – PersonEntity:
          Name:
            NameFull: Kolstad A
      – PersonEntity:
          Name:
            NameFull: Tjønnfjord GE
      – PersonEntity:
          Name:
            NameFull: Lie BA
      – PersonEntity:
          Name:
            NameFull: Griffioen M
      – PersonEntity:
          Name:
            NameFull: Lehmann S
      – PersonEntity:
          Name:
            NameFull: Osnes LT
      – PersonEntity:
          Name:
            NameFull: Buechner J
      – PersonEntity:
          Name:
            NameFull: Garcia KC
      – PersonEntity:
          Name:
            NameFull: Schumacher TN
      – PersonEntity:
          Name:
            NameFull: van Veelen PA
      – PersonEntity:
          Name:
            NameFull: Leisegang M
      – PersonEntity:
          Name:
            NameFull: Jacobsen SEW
      – PersonEntity:
          Name:
            NameFull: Woll P
      – PersonEntity:
          Name:
            NameFull: Olweus J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1546-1696
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Nature biotechnology
              Type: main
ResultId 1